Company Profile
Public information reviewedAlpha Cognition Inc.
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada.
USNASDAQ: ACOG
Follow
More
- Public sources
- 1 reviewed
- Published leadership records
- 7
- Last reviewed
- Sep 15, 2026

